News

The AAM S&P 500 High Dividend Value ETF (NYSEARCA:SPDV) screens the S&P 500 for companies that pair above-average yields with above-average free cash flow, then equal-weights five names from each of ten sectors. SPDV functions as a future-aristocrats farm system, and the holdings list reads like one: a confirmed Dividend King, two near-aristocrats, and three ... Equal Weighted Dividends Across 54 Stocks Deliver 24.7% Returns and Growing Payouts

Johnson & Johnson (JNJ) just told Wall Street it will sit out the most lucrative drug race of the decade. The decision came straight from the top, at a public event in Washington, on June 16, and it surprised investors who assumed a large drugmaker like J&J would want a piece of the ...

Alphabet's inclusion in the Dow gives the 130-year-old blue-chip index a dose of the same mega-cap tech trade already dominating the Nasdaq 100.

Most retirees shop for dividend portfolios the same way people shop for cars: they focus on what they get today. A portfolio yielding $90,000 a year feels like the retirement equivalent of driving a Ferrari off the lot. Another portfolio paying only $45,000 can look more like a dependable Honda. The mistake is assuming the race ... The Dividend Portfolio That Starts Like A Honda And Ends Like A Ferrari

Income investors heading into the back half of 2026 face a familiar tension: stretched broad-market multiples versus a shrinking pool of stocks that actually grow their dividends through cycles. The classic Dividend Aristocrat screen, 25-plus years of consecutive increases, surfaces the right kind of name. We pair two bona fide Aristocrats with one reliable dividend ... 3 Quality Dividend Aristocrats to Buy in June

Most retirees treat cruise fares like an occasional splurge funded from cash on hand or a withdrawal from the portfolio. There is another way to frame the same expense: build an income stream that quietly pays for two trips every year, leaving the principal untouched. Three Budgets, Four Yields The core equation is the same ... The Portfolio That Quietly Pays For Two Cruises Every Year

Big Pharma's patent cliffs are forcing acquirers to hunt for revenue-producing biotech assets before rivals snap them up, and three names keep surfacing in deal speculation. One already has a natural buyer embedded in its business and a share price that looks like a mistake.

Picture two retirees with the same nest egg making opposite choices. One locks in $80,000 a year today with little growth. The other accepts $50,000 a year today, growing at 8% annually. For most of a decade, the first retiree looks like the obvious winner. Then the math quietly turns. The dividend-growth bet takes roughly ... The Retirement Income Bet That Takes 12 Years To Pay Off

Low-risk stocks are back in vogue.

In mid-June 2026, Johnson & Johnson reported strong clinical data for TALVEY combinations in relapsed/refractory multiple myeloma, positive Phase 2/3 ENERGY results for IMAAVY in warm autoimmune hemolytic anemia, and broader U.S. availability of its TECNIS PureSee extended depth of focus intraocular lens. These advances highlight Johnson & Johnson’s push into bispecific oncology therapies, rare autoantibody diseases, and premium MedTech optics, reinforcing its position across high‑value...

Before its fifty percent surge, the drug giant was repeatedly telling a story about its future that the market seemed to be ignoring.

For many investors, real estate seems like the default path to passive income. Buy a rental, collect the checks, repeat. In reality, many landlords discover they have purchased a second job, complete with late-night phone calls, surprise repairs, insurance headaches, and months when the rent simply doesn’t arrive. Instead, some investors build portfolios that generate ... How To Build A $7,500 Monthly Paycheck Without Flipping A Single House

While the market fixates on a disruptive quarter for Stryker stock, the company's powerful ability to convert profit into hard cash reveals a deeper, under-appreciated resilience.

The Fed’s pivot toward a rate-hike bias changes the math for a 67-year-old with $1.5 million in a 401k. Bond reinvestment risk just got more interesting, but equity duration got more dangerous. My answer is three Dividend Kings whose payouts have survived every rate regime since the Eisenhower administration. Here is the safety case for ... 67 With $1.5 Million. Here Are My 3 Defensive Anchors

Intuitive Surgical, Inc. (NASDAQ:ISRG) was among the stocks Jim Cramer discussed as he said that the Iran peace negotiations could trigger an oil glut, cool inflation, and pull interest rates down. Inquiring about the stock, a caller asked if it is a buy. Cramer replied: Too much competition, too much competition… Used to be king, […]

The latest Powerball jackpot stood at roughly $269 million, with a cash option of about $120.5 million before taxes. That would solve all your financial problems, but the odds are not great: roughly 1 in 292 million. If your goal is simply to create a $5,000 monthly dividend paycheck, however, a Powerball win is the ... You Don’t Need a Powerball Jackpot To Build A $5,000 Monthly Dividend Paycheck

AMGN's biosimilars business is driving growth, with new launches and a deep pipeline helping offset patent losses in key branded drugs.

The drugmaker has successfully replaced its former blockbuster, but buying into that victory today means paying a steep premium for its next act.

Eric Lenard comes to the new position with more than two decades of experience in medtech finance, as Medtronic steps up its investment in innovation.

US manufacturers defy the tragedy of the commons by jointly sponsoring efforts to attract new talent amid onshoring.

The average federal student loan borrower leaves school owing roughly $38,000, though balances of $50,000 or more are common among graduate students and many private-college graduates. Depending on interest rates and repayment terms, that debt can create a substantial monthly obligation just as a young adult is trying to rent an apartment, buy a first ... This Is the Dividend Portfolio That Pays Off Your Kid’s Student Loans

A 67-year-old with a $650,000 portfolio and a Social Security check looks at New Orleans and sees a city that seems surprisingly affordable compared with many coastal retirement destinations. Home prices remain below those in much of Florida, California, and the Northeast, and the food, culture, and walkability are hard to replicate elsewhere. The question ... You Have $650,000. Is It Enough To Retire In The Big Easy?

Johnson & Johnson (NYSE:JNJ) is investing more than $1b to expand its Vision manufacturing, packaging, and distribution facilities in Jacksonville, Florida. The expansion is part of a broader $55b U.S. investment initiative focused on manufacturing and R&D. The Jacksonville site will scale domestic production capacity for ACUVUE contact lenses using advanced manufacturing technologies. Johnson & Johnson enters this expansion with its stock at $228.39 and a long track record in healthcare...

While Wall Street fretted over the future of its biggest blockbuster, a pair of new drugs were already showing the company's next act was well underway.

AbbVie will acquire the clinical-stage biotech’s pipeline of candidates for inflammatory and immunological diseases.

Uncle Ralph owns a few rental properties, drives an old truck, and is rumored to be worth a fortune. At family gatherings, people joke about being remembered in the will. The problem is he may live another 20 years, spend more than expected, or leave the money somewhere else entirely. The math suggests a better ... Don’t Wait For Your Rich Uncle To Die. Build Your Own Inheritance With This Portfolio

ABBV's successful transition beyond Humira and growth from newer medicines give it an edge over MRK in this oncology-immunology showdown.

The average American household spent about $200 per month on gasoline according to the latest federal expenditure data. With gasoline prices remaining elevated in 2026, many families are paying considerably more. Most people treat their gas bill as a fact of life. Investors can treat it as an income target. The goal is simple: build ... The Portfolio That Quietly Pays For Your Gasoline Forever

Nanobiotix S.A. (NASDAQ:NBTX) is one of the best small cap stocks to buy for the long term. Nanobiotix S.A. (NASDAQ:NBTX) announced on June 2 an update on operational progress and reported financial results for the first quarter of 2026. The company reported €42.1 million in cash and cash equivalents as of March 31, 2026, adding that it […]

AbbVie will acquire the clinical-stage biotech’s pipeline of candidates for inflammatory and immunological diseases.